Suppr超能文献

从人肺癌组织中分离尿胰蛋白酶抑制剂样抑制剂。

Isolation of urinary trypsin inhibitor-like inhibitor from human lung cancer tissue.

作者信息

Okumichi T, Nishiki M, Takasugi S, Toki N, Ezaki H

出版信息

Cancer Res. 1984 May;44(5):2011-5.

PMID:6424935
Abstract

In the present study, a trypsin inhibitor was first extracted from lung cancer tissue and purified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A final yield of 20 to 60 micrograms of inhibitor with a specific activity of 2040 units/mg of protein was obtained from 1 g of original lung cancer tissue. This inhibitor inhibited trypsin strongly, plasma kallikrein weakly, and plasmin more weakly, and its molecular weight was approximately 43,000 to 45,000 as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Its antigenicity was confirmed to be quite the same as that of human urinary trypsin inhibitor by double immunodiffusion, immunoelectrophoresis, and neutralization with anti-urinary trypsin inhibitor rabbit immunoglobulin.

摘要

在本研究中,首先从肺癌组织中提取胰蛋白酶抑制剂,并通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳进行纯化。从1克原始肺癌组织中最终获得了20至60微克的抑制剂,其比活性为2040单位/毫克蛋白质。该抑制剂对胰蛋白酶有强烈抑制作用,对血浆激肽释放酶抑制作用较弱,对纤溶酶的抑制作用更弱,通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳测定其分子量约为43,000至45,000。通过双向免疫扩散、免疫电泳以及用抗人尿胰蛋白酶抑制剂兔免疫球蛋白进行中和试验,证实其抗原性与人类尿胰蛋白酶抑制剂完全相同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验